Mas S - Search Results

1

Molecular evidence of field cancerization initiated by diabetes in colon cancer patients.

Del Puerto-Nevado L, Minguez P, Corton M, Solanes-Casado S, Prieto I, Mas S, Sanz AB, Gonzalez-Alonso P, Villaverde C, Portal-Nuñez S, Aguilera O, Gomez-Guerrero C, Esbrit P, Vivanco F, Gonzalez N, Ayuso C, Ortiz A, Rojo F, Egido J, Alvarez-Llamas G, Garcia-Foncillas J; DiabetesCancerConnect Consortium. Del Puerto-Nevado L, et al. Among authors: mas s. Mol Oncol. 2019 Apr;13(4):857-872. doi: 10.1002/1878-0261.12438. Epub 2019 Feb 16. Mol Oncol. 2019. PMID: 30628165 Free PMC article.

2

Serine 132 is the C3 covalent attachment point on the CH1 domain of human IgG1.

Vidarte L, Pastor C, Mas S, Blázquez AB, de los Rios V, Guerrero R, Vivanco F. Vidarte L, et al. Among authors: mas s. J Biol Chem. 2001 Oct 12;276(41):38217-23. doi: 10.1074/jbc.M104870200. Epub 2001 Jul 10. J Biol Chem. 2001. PMID: 11447230 Free article.

3

Simvastatin reduces NF-kappaB activity in peripheral mononuclear and in plaque cells of rabbit atheroma more markedly than lipid lowering diet.

Hernández-Presa MA, Ortego M, Tuñón J, Martín-Ventura JL, Mas S, Blanco-Colio LM, Aparicio C, Ortega L, Gómez-Gerique J, Vivanco F, Egido J. Hernández-Presa MA, et al. Among authors: mas s. Cardiovasc Res. 2003 Jan;57(1):168-77. doi: 10.1016/s0008-6363(02)00619-3. Cardiovasc Res. 2003. PMID: 12504826

4

Proteomic analysis of human vessels: application to atherosclerotic plaques.

Duran MC, Mas S, Martin-Ventura JL, Meilhac O, Michel JB, Gallego-Delgado J, Lázaro A, Tuñon J, Egido J, Vivanco F. Duran MC, et al. Among authors: mas s. Proteomics. 2003 Jun;3(6):973-8. doi: 10.1002/pmic.200300389. Proteomics. 2003. PMID: 12833522

5

Isolation of circulating human monocytes with high purity for proteomic analysis.

Gonzalez-Barderas M, Gallego-Delgado J, Mas S, Duran MC, Lázaro A, Hernandez-Merida S, Egido J, Vivanco F. Gonzalez-Barderas M, et al. Among authors: mas s. Proteomics. 2004 Feb;4(2):432-7. doi: 10.1002/pmic.200300629. Proteomics. 2004. PMID: 14760713

6

Quest for novel cardiovascular biomarkers by proteomic analysis.

Vivanco F, Martín-Ventura JL, Duran MC, Barderas MG, Blanco-Colio L, Dardé VM, Mas S, Meilhac O, Michel JB, Tuñón J, Egido J. Vivanco F, et al. Among authors: mas s. J Proteome Res. 2005 Jul-Aug;4(4):1181-91. doi: 10.1021/pr0500197. J Proteome Res. 2005. PMID: 16083268 Review.

7

Characterization of the human atheroma plaque secretome by proteomic analysis.

Durán MC, Martín-Ventura JL, Mas S, Barderas MG, Dardé VM, Jensen ON, Egido J, Vivanco F. Durán MC, et al. Among authors: mas s. Methods Mol Biol. 2007;357:141-50. doi: 10.1385/1-59745-214-9:141. Methods Mol Biol. 2007. PMID: 17172685

8

Lipid cartography of atherosclerotic plaque by cluster-TOF-SIMS imaging.

Mas S, Touboul D, Brunelle A, Aragoncillo P, Egido J, Laprévote O, Vivanco F. Mas S, et al. Analyst. 2007 Jan;132(1):24-6. doi: 10.1039/b614619h. Epub 2006 Nov 21. Analyst. 2007. PMID: 17180175

9

Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques.

Durán MC, Martín-Ventura JL, Mohammed S, Barderas MG, Blanco-Colio LM, Mas S, Moral V, Ortega L, Tuñón J, Jensen ON, Vivanco F, Egido J. Durán MC, et al. Among authors: mas s. Eur J Pharmacol. 2007 May 7;562(1-2):119-29. doi: 10.1016/j.ejphar.2007.01.077. Epub 2007 Feb 8. Eur J Pharmacol. 2007. PMID: 17336287

10

Proteomics in atherosclerosis.

Martinez-Pinna R, Martin-Ventura JL, Mas S, Blanco-Colio LM, Tuñon J, Egido J. Martinez-Pinna R, et al. Among authors: mas s. Curr Atheroscler Rep. 2008 Jun;10(3):209-15. doi: 10.1007/s11883-008-0033-z. Curr Atheroscler Rep. 2008. PMID: 18489848 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters